TAK-981
TAK-981 is a selective the SUMOylation enzymatic cascade inhibitor, has potential immune-activating and antineoplastic activities. (In Vitro) :Subasumstat (TAK-981) is able to increase the production of type 1 IFN, thereby increasing type 1 IFN-mediated signaling, activating innate effector cells and enhancing the antitumor innate immune responses. (In Vivo) :A single sub-cutaneous injection of Subasumstat (TAK-981) in naive Balb/c mice at the brachial lymph nodes induces activation of DCs.
Product Specifications
CAS Number
1858276-04-6
Product Name Alternative
Subasumstat
Field of Research
Epigenetics & Chromatin
Purity
>98% (HPLC)
Solubility
DMSO:75 mg/mL (129.74 mM; Need ultrasonic)
Smiles
Cc1c ([C@@H]2NCCc (cc3) c2cc3Cl) cc (C (c2c (N[C@H] (C[C@@H]3COS (N) (=O) =O) C[C@@H]3O) ncnc2) =O) s1
Molecular Formula
C25H28ClN5O5S2
Molecular Weight
578.1
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma, local bronchioloalveolar carcinoma (E(L858R) Mutation)
